Healthcare >> CEO Interviews >> June 2, 2003
GERARD G. GORMAN has served as Vice President and Chief Financial
Officer of Immunomedics, Inc., since September 2001. Prior to that time,
Mr. Gorman was employed by the Animal Health Division of Pfizer Inc.,
where he was Vice President, Finance and Information Technology and
Chief Financial Officer from September 1996. While at Pfizer, he
directed strategic and long-range financial planning as well as
negotiations related to acquisitions, divestitures and outsourcing of
support operations. Mr. Gorman previously held a variety of other senior
positions at Pfizer, including: Senior Director, Corporate Treasury
Operations; Director, Administration -International Pharmaceuticals
Group; Director, Finance/Assistant Treasurer International; and Manager,
Benefit Financing/Senior Financial Analyst. Mr. Gorman completed a BA in
Economics from Fairfield University and received his MBA from Adelphi
University. He also serves as a member of the Board of Directors of the
Northern Ireland Children's Enterprise. Profile
Mr. Gorman: Immunomedics is a biopharmaceutical company focused
on the development, manufacture and marketing of monoclonal
antibody
